Ran-Chan Twitter 100619 気になる話題、誰よりも早く 高感度で低侵襲なアレルギー診断技術を提供するベンチャー [ふーん なるほどサイエンス]
高感度で低侵襲なアレルギー診断技術を提供するベンチャー カルボキシル化DLCたんぱくチップの応用酵素医学研究所株式会社
http://www.jst.go.jp/pr/info/info739/
先日紹介した珈琲・紅茶好きへの朗報 心疾患
RT @bbcscitech Drinking several cups of coffee or tea a day appears to protect against heart disease, a 13-year ...
http://bit.ly/bk3Rd2
何?身長は遺伝的に決まる?
RT @NatureNews Genetics tells tall tales
http://ff.im/-mp7Gy
薬剤抵抗性がんに対する新たは分子的な発見
RT @physorg_com Molecular discovery suggests new strategy to fight cancer drug resistance
http://bit.ly/dvTVBw
血小板検査
RT @physorg_com Bioengineers create simulator to test blood platelets in virtual heart attacks http://bit.ly/96Pesp
RT @NatureNews RT @bongopondit: The genetics basis of height. As expected, the answer is complicated.
http://ff.im/-mp7Gy (via @NatureNews)
RT @physorg_com Genetic heritability may be hidden deeper than previously thought
http://bit.ly/9yYmQ9
RT @newscientist Unknown genome. What we still don't know about our DNA >
http://bit.ly/9D1fS5
RT @nytimesscience Risk to Elderly: Hallucinations in the Hospital
http://nyti.ms/diFueY
http://www.jst.go.jp/pr/info/info739/
先日紹介した珈琲・紅茶好きへの朗報 心疾患
RT @bbcscitech Drinking several cups of coffee or tea a day appears to protect against heart disease, a 13-year ...
http://bit.ly/bk3Rd2
何?身長は遺伝的に決まる?
RT @NatureNews Genetics tells tall tales
http://ff.im/-mp7Gy
薬剤抵抗性がんに対する新たは分子的な発見
RT @physorg_com Molecular discovery suggests new strategy to fight cancer drug resistance
http://bit.ly/dvTVBw
血小板検査
RT @physorg_com Bioengineers create simulator to test blood platelets in virtual heart attacks http://bit.ly/96Pesp
RT @NatureNews RT @bongopondit: The genetics basis of height. As expected, the answer is complicated.
http://ff.im/-mp7Gy (via @NatureNews)
RT @physorg_com Genetic heritability may be hidden deeper than previously thought
http://bit.ly/9yYmQ9
RT @newscientist Unknown genome. What we still don't know about our DNA >
http://bit.ly/9D1fS5
RT @nytimesscience Risk to Elderly: Hallucinations in the Hospital
http://nyti.ms/diFueY
コメント 0